ROYAL BANK OF CANADA - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 40 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,000
-25.0%
5,094
-5.1%
0.00%
Q2 2023$4,000
+100.0%
5,368
+11.4%
0.00%
Q1 2023$2,000
-33.3%
4,8200.0%0.00%
Q4 2022$3,0000.0%4,820
-5.8%
0.00%
Q3 2022$3,000
-57.1%
5,119
+6.2%
0.00%
Q2 2022$7,000
-61.1%
4,8200.0%0.00%
Q1 2022$18,000
+12.5%
4,820
+141.0%
0.00%
Q4 2021$16,0002,0000.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$294,0000.05%
Shaolin Capital Management LLC 275,000$1,034,0000.03%
Spectrum Management Group, LLC 5,030$19,0000.00%
Veritable, L.P. 43,551$164,0000.00%
ALPS ADVISORS INC 45,083$170,0000.00%
ETF MANAGERS GROUP, LLC 13,187$34,0000.00%
Qube Research & Technologies Ltd 24,179$91,0000.00%
NORTHERN TRUST CORP 44,476$167,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 301,110$1,132,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders